REQUEST A DEMO
Total
USD $0.00
Search more companies

Guangdong Hybribio Biotech Co.,Ltd. (广东凯普生物科技股份有限公司) (China)

Main Activities: Biological Product (except Diagnostic) Manufacturing
Full name: Guangdong Hybribio Biotech Co.,Ltd. Profile Updated: March 29, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Guangdong Hybribio Biotech Co.,Ltd. (广东凯普生物科技股份有限公司) is based in China, with the head office in Chaozhou. It operates in the Biological Product (except Diagnostic) Manufacturing industry. The enterprise was incorporated on June 13, 2003. Guangdong Hybribio Biotech Co.,Ltd. (广东凯普生物科技股份有限公司) currently employs 2,205 (2024) people. In Q3C2025, the company reported a net sales revenue drop of 20.38%. Its’ total assets recorded a negative growth of 15.93%. In 2025, Guangdong Hybribio Biotech Co.,Ltd. (广东凯普生物科技股份有限公司)’s net profit margin increased by 26.68%.

Headquarters
D5-3-3-4 Community, North High-tech Zone, Chaozhou Economic Development Pilot Zone, Guangdong Province
Chaozhou; Guangdong; Postal Code: 521000

Contact Details: Purchase the Guangdong Hybribio Biotech Co.,Ltd. (广东凯普生物科技股份有限公司) report to view the information.

Basic Information
Total Employees:
Purchase the Guangdong Hybribio Biotech Co.,Ltd. (广东凯普生物科技股份有限公司) report to view the information.
Outstanding Shares:
Purchase the Guangdong Hybribio Biotech Co.,Ltd. (广东凯普生物科技股份有限公司) report to view the information.
Registered Capital:
Purchase the Guangdong Hybribio Biotech Co.,Ltd. (广东凯普生物科技股份有限公司) report to view the information.
Financial Auditors:
Purchase the Guangdong Hybribio Biotech Co.,Ltd. (广东凯普生物科技股份有限公司) report to view the information.
Incorporation Date:
June 13, 2003
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director
Purchase this report to view the information.
General Manager
Purchase this report to view the information.
Deputy General Manager
Purchase this report to view the information.
Standing Deputy General Manager
Ownership Details
Purchase this report to view the information.
29.88%
Purchase this report to view the information.
6.21%
Purchase this report to view the information.
4.76%
Purchase this report to view the information.
2.26%
Purchase this report to view the information.
1.69%
Subsidiaries
Beijing Kaipu Huijian Clinic Co., Ltd.
100%
Beijing Kaipu Huijian Medical Management Co., Ltd
100%
Beijing Kangzhong Health Management Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Guangdong Hybribio Biotech Co.,Ltd. (广东凯普生物科技股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-20.38%
Total Operating Revenue
-20.84%
Operating Profit
62.6%
Net Profit/Loss for the Period
52.74%
Total Assets
-15.93%
Total Equity
-18.63%
Operating Profit Margin
39.7%
Net Profit Margin
26.68%
Return on Equity (ROE)
3.66%
Debt / Equity
971%
Quick Ratio
-1457.27%
Cash Ratio
-0.59%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?